COVINNOVATIONS Trademark

Trademark Overview

On Thursday, February 11, 2021, a trademark application was filed for COVINNOVATIONS with the United States Patent and Trademark Office. The USPTO has given the COVINNOVATIONS trademark a serial number of 90525950. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 11, 2022. This trademark is owned by Schaefflertanz Corporation. The COVINNOVATIONS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including COVID-19; Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including COVID-19

Medical diagnostic testing, monitoring and reporting services relating to infectious disease, including COVID-19; Medical services, namely, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including COVID-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; Medical testing for diagnostic or treatment purposes relating to infectious disease, including COVID-19; Medical testing for diagnostic or treatment purposes in the field of infectious disease, including COVID-19

Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing for viruses, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing of nucleic acids for infectious disease, including COVID-19

Research and development and consultation related thereto in the field of infectious disease, including COVID-19 testing; Research and development in the field of infectious disease, including COVID-19 testing; Research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including COVID-19; Research and development of technology in the field of infectious disease, including COVID-19 testing; Research and development services in the field of antibodies relating to infectious disease, including COVID-19; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including COVID-19; Scientific research and development relating to infectious disease, including COVID-19; Pharmaceutical research and development relating to infectious disease, including COVID-19
covinnovations

General Information

Serial Number90525950
Word MarkCOVINNOVATIONS
Filing DateThursday, February 11, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including COVID-19; Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including COVID-19
Goods and ServicesMedical diagnostic testing, monitoring and reporting services relating to infectious disease, including COVID-19; Medical services, namely, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including COVID-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; Medical testing for diagnostic or treatment purposes relating to infectious disease, including COVID-19; Medical testing for diagnostic or treatment purposes in the field of infectious disease, including COVID-19
Goods and ServicesDiagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing for viruses, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing of nucleic acids for infectious disease, including COVID-19
Goods and ServicesResearch and development and consultation related thereto in the field of infectious disease, including COVID-19 testing; Research and development in the field of infectious disease, including COVID-19 testing; Research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including COVID-19; Research and development of technology in the field of infectious disease, including COVID-19 testing; Research and development services in the field of antibodies relating to infectious disease, including COVID-19; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including COVID-19; Scientific research and development relating to infectious disease, including COVID-19; Pharmaceutical research and development relating to infectious disease, including COVID-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, May 16, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 16, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSchaefflertanz Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89117

Trademark Events

Event DateEvent Description
Monday, April 11, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 11, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 27, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, September 27, 2021FINAL REFUSAL E-MAILED
Monday, September 27, 2021FINAL REFUSAL WRITTEN
Saturday, September 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 8, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 8, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 7, 2021ASSIGNED TO EXAMINER
Sunday, May 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 15, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

covinnovations disease including covid infectious testing diagnostic medical relating research development